Advanced Biomed (ADVB) vs BioNexus Gene Lab (BGLC)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Advanced Biomed is the larger company by market cap ($10.3 million vs $3.9 million), about 2.6 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Head-to-head
| Metric | ADVB | BGLC |
|---|---|---|
| Share price | $6.21 | $1.34 |
| Market cap | $10.26M | $3.93M |
| 1-day change | -2.66% | +6.77% |
| YTD return | +6.34% | — |
| 1-year return | -34.77% | — |
| P/E ratio (TTM) | 1.30 | — |
| EPS (TTM) | $4.79 | $-1.26 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $24.23 | $5.89 |
| 52-week low | $3.61 | $1.07 |
| Distance from 52-week high | -74.37% | -77.24% |
| Average volume | 1.77M | 10.82K |
| Shares outstanding | 1.65M | 2.93M |
| Sector | Health Care | Health Care |
| Industry | Medical Specialities | Medical Specialities |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Advanced Biomed is about 2.6 times larger than BioNexus Gene Lab by market value ($10.26M vs $3.93M).
ADVB vs BGLC FAQ
Which is bigger, Advanced Biomed or BioNexus Gene Lab?
Advanced Biomed (ADVB) is larger, with a market capitalization of $10.26M compared with $3.93M for BioNexus Gene Lab (BGLC).
Are Advanced Biomed and BioNexus Gene Lab in the same industry?
Yes. Both are classified in the Medical Specialities industry within the Health Care sector.